Boston, MA, United States of America

Richard Kuo-An Tsai

This inventor holds 1 USPTO granted patent. Top assignee: University of Pennsylvania. Active years: 2015.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Richard Kuo-An Tsai. Retrieved from https://idiyas.com/inventor/richard-kuo-an-tsai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2015

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Richard Kuo-An Tsai: Innovator in Viral Particle Technology.

Introduction

Richard Kuo-An Tsai is a prominent inventor based in Boston, MA. He has made significant contributions to the field of viral particle technology. His innovative work focuses on enhancing the longevity of viral particles in biological systems.

Latest Patents

Richard Kuo-An Tsai holds a patent titled "Protection of virus particles from phagocytosis by expression of CD47." This invention relates to a viral particle with a radius of less than about 1 µm, which includes at least one peptide comprising a biologically active portion of CD47. The patent outlines a method for increasing the life of a particle in vivo in mammals. This method involves expressing the peptide in a viral particle and administering it to a mammal, resulting in a longer half-life compared to identical viral particles without CD47.

Career Highlights

Richard Kuo-An Tsai is affiliated with the University of Pennsylvania, where he continues to advance research in his field. His work has implications for medical applications, particularly in improving the efficacy of viral therapies.

Collaborations

Richard collaborates with Dennis E Discher, a fellow researcher, to further explore the potential of his inventions in practical applications.

Conclusion

Richard Kuo-An Tsai is a notable inventor whose work on viral particles has the potential to transform therapeutic approaches in medicine. His innovative patent demonstrates a significant advancement in the field of virology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…